The FDA released its quarterly list of drugs under review for potential safety issues. Included are Pfizer's cancer treatment Sutent, Wyeth and Progenics Pharmaceuticals' constipation drug Relistor, and Medicis Pharmaceutical's antibiotic Solodyn. The agency reiterated that appearance on the list "does not mean that FDA has identified a causal relationship between the drug and the listed risk."

Full Story:

Related Summaries